XPLRA.OL(XPLRA.OL)
XPLRA.OL
No analyst ratings available
No analyst price targets available for XPLRA.OL
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $2.03B | $2.24B | $2.48B | $2.61B |
| Low | $1.94B | $2.12B | $2.47B | $2.48B |
| High | $2.11B | $2.39B | $2.48B | $2.74B |
| EBITDA Avg | $84M | $93M | $103M | $108M |
| Low | $81M | $88M | $102M | $103M |
| High | $87M | $99M | $103M | $114M |
| EBIT Avg | $-52M | $-58M | $-64M | $-67M |
| Low | $-54M | $-61M | $-64M | $-71M |
| High | $-50M | $-55M | $-64M | $-64M |
| Net Income Avg | $162M | $198M | $281M | $369M |
| Low | $162M | $184M | $273M | $345M |
| High | $229M | $264M | $347M | $394M |
| EPS Avg | $3.47 | $4.07 | $5.60 | $6.75 |
| Low | $2.96 | $3.36 | $5.00 | $6.31 |
| High | $4.18 | $4.83 | $6.35 | $7.20 |
| Analysts (Rev / EPS) | 5 / 4 | 5 / 4 | 5 / 5 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $547M | $625M | $485M | $595M | $665M | $717M |
| Low | $529M | $605M | $470M | $575M | $643M | $693M |
| High | $573M | $656M | $509M | $624M | $697M | $751M |
| EBITDA Avg | $23M | $26M | $20M | $25M | $28M | $30M |
| Low | $22M | $25M | $19M | $24M | $27M | $29M |
| High | $24M | $27M | $21M | $26M | $29M | $31M |
| EBIT Avg | $-14M | $-16M | $-12M | $-15M | $-17M | $-18M |
| Low | $-15M | $-17M | $-13M | $-16M | $-18M | $-19M |
| High | $-14M | $-16M | $-12M | $-15M | $-17M | $-18M |
| Net Income Avg | $45M | $61M | $24M | $53M | $72M | $81M |
| Low | $44M | $58M | $23M | $50M | $69M | $78M |
| High | $48M | $64M | $25M | $56M | $76M | $86M |
| EPS Avg | $0.95 | $1.27 | $0.50 | $1.10 | $1.50 | $1.70 |
| Low | $0.91 | $1.21 | $0.48 | $1.05 | $1.44 | $1.63 |
| High | $1.01 | $1.35 | $0.53 | $1.17 | $1.59 | $1.81 |
| Analysts (Rev / EPS) | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 |